Articles from Instil Bio, Inc.

Instil Bio Reports Third Quarter 2026 Financial Results and Provides Corporate Update
DALLAS, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (“Instil”) (Nasdaq: TIL), a biotechnology company building a portfolio of asset-focused subsidiaries to develop novel therapies for unmet medical needs, today reported its third quarter 2026 financial results and provided a corporate update.
By Instil Bio, Inc. · Via GlobeNewswire · November 16, 2026
Articles from Instil Bio, Inc. | WKOW